Detalhe da pesquisa
1.
Therapy-induced APOBEC3A drives evolution of persistent cancer cells.
Nature
; 620(7973): 393-401, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37407818
2.
Synergistic effect of pacritinib with erlotinib on JAK2-mediated resistance in epidermal gowth factor receptor mutation-positive non-small cell lung Cancer.
Exp Cell Res
; 344(2): 194-200, 2016 06 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27180268
3.
Downregulation of TBXAS1 in an iron-induced malignant mesothelioma model.
Cancer Sci
; 106(10): 1296-302, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26211743
4.
A new human lung adenocarcinoma cell line harboring the EML4-ALK fusion gene.
Jpn J Clin Oncol
; 44(10): 963-8, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25170107
5.
MUC1-C Is a Common Driver of Acquired Osimertinib Resistance in NSCLC.
J Thorac Oncol
; 19(3): 434-450, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37924972
6.
Crizotinib for recurring non-small-cell lung cancer with EML4-ALK fusion genes previously treated with alectinib: A phase II trial.
Thorac Cancer
; 12(5): 643-649, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33470536
7.
Landscape of Acquired Resistance to Osimertinib in EGFR-Mutant NSCLC and Clinical Validation of Combined EGFR and RET Inhibition with Osimertinib and BLU-667 for Acquired RET Fusion.
Cancer Discov
; 8(12): 1529-1539, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30257958
8.
Non-Small Cell Lung Cancer Cells Acquire Resistance to the ALK Inhibitor Alectinib by Activating Alternative Receptor Tyrosine Kinases.
Cancer Res
; 76(6): 1506-16, 2016 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26719536
9.
Protocol Design for the Bench to Bed Trial in Alectinib-Refractory Non-Small-Cell Lung Cancer Patients Harboring the EML4-ALK Fusion Gene (ALRIGHT/OLCSG1405).
Clin Lung Cancer
; 17(6): 602-605, 2016 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27405684
10.
Mechanisms of Acquired Resistance to ALK Inhibitors and the Rationale for Treating ALK-positive Lung Cancer.
Cancers (Basel)
; 7(2): 763-83, 2015 Apr 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-25941796
11.
Programmed cell death protein 1 and programmed death-ligand 1 are expressed on the surface of some small-cell lung cancer lines.
Am J Cancer Res
; 5(4): 1553-7, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26101718
12.
Cisplatin-induced hyponatremia in malignancy: comparison between brand-name and generic formulation.
Drug Des Devel Ther
; 8: 2401-8, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25584019
13.
Skin involvement in diffuse large B-cell lymphoma detected using positron emission tomography.
Thorac Cancer
; 5(6): 581-2, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26767056